← Back to Clinical Trials
Recruiting NCT06837298

The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery

Trial Parameters

Condition Muscle Damage
Sponsor PepsiCo Global R&D
Study Type INTERVENTIONAL
Phase N/A
Enrollment 76
Sex ALL
Min Age 18 Years
Max Age 45 Years
Start Date 2025-02-07
Completion 2025-09-30
Interventions
Placebo control capsulesPeptiStrong® supplement capsules with same appearance as placebo capsulesPeptiStrong® supplement capsules following muscle damaging exercise on Day 14

Brief Summary

To investigate the effect of Vicia faba protein concentrate, a protein derived from Fava bean extract, on delayed onset muscle soreness (DOMS). Participants receive either 2.4g/day of PeptiStrong® supplement capsules or placebo capsules for 14 days until a strenuous exercise session. For the last 3 days, 2/3 of them stay on the same treatment and 1/3 of them switch from placebo to PeptiStrong®.

Eligibility Criteria

Inclusion Criteria: * Males and females 18 - 45 years of age. * Willing to fast overnight on the 4 testing occasions. * Participants agree to abstain from taking additional supplements throughout the testing period, with particular emphasis placed upon protein-based products (e.g., whey or casein based protein powders; animal derived protein hydrolysates; natural supplements constituted of vegetative protein hydrolysates from rice, fava bean, pea, carrot, spirulina, broccoli, potatoes; marine derived secondary metabolite products or protein hydrolysates including Omega-3 capsules or DHA). * Moderately active (exercise 3-5 days per week) * Fluent in reading, writing, and speaking English * Participants agree to maintain their normal diet and perform only light to moderate exercise for the duration of the study. * BMI between 18.5 and 29.9 kg/m2 * Participants agree to refrain from consuming alcohol in the 48 hours leading up to a test day. * Willingness to complete questionnaires, recor

Related Trials